Therapies for Inherited Neuropathies Inc (EIN 815350594) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

Steven F O'Donnell

Phone

4102454555

Tax Period

2024-01-01 to 2024-12-31

Therapies for Inherited Neuropathies Inc, founded in 2017, is a small nonprofit in the Diseases & Disorders sector that reported $412K in total revenue in fiscal year 2024. Revenue surged 77% from the prior year, signaling strong growth momentum. Expenses of $503K exceeded revenue, resulting in a 22% operating deficit.

Mission

Advocacy and support for treatment and prevention of illnesses or conditions that are hereditary and passed from parent to offspring.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $416,257

Program Service Revenue $0

Investment Income $24,968

Other Revenue $-29,102

TOTAL REVENUE $412,123

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $498,313

Other Expenses $503,277

TOTAL EXPENSES $503,277

Year-over-Year Comparison

	2024	2023	Change
Revenue	$412,123	$232,876	+0.8%
Expenses	$503,277	$119,104	+3.2%
Net Income	$-91,154	$113,772	-1.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Steven F O'Donnell	Chief Executive Officer	25.00	Officer Director	$0	$0	$0
Sherri E O'Donnell	Secretary	2.00	Officer Director	$0	$0	$0
Tom Haslach	Board Member	2.00	Director	$0	$0	$0
Steve O'Connell	Treasurer	2.00	Officer Director	$0	$0	$0
Jimmy Reyes	Board Member	2.00	Director	$0	$0	$0
Robert Shaffer	Board Member	2.00	Director	$0	$0	$0
David Todd	Board Member	2.00	Director	$0	$0	$0
David Norcom	Board Member	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$412,123	$503,277	$350,964	$-91,154
2023	$232,876	$119,104	$423,602	$113,772
2023	$232,876	$119,104	$423,602	$113,772
2022	$277,056	$370,258	$313,614	$-93,202
2021	$191,310	$222,193	$403,044	$-30,883
2020	$379,008	$195,292	$433,926	$183,716
2019	$222,300	$146,566	$249,968	$75,734

Therapies for Inherited Neuropathies Inc